Atlas Trials

Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment

Clinical trial NCT02336399 · UNKNOWN

Trial details

NCT number
NCT02336399
Sponsor
Beijing Ditan Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Chronic Hepatitis B
Start date
2008-09-01
Primary completion
2016-12-01
Enrollment
420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.